PREVENA
Device
KCI USA, Inc
Total Payments
$22.9M
Transactions
19,098
Doctors
11,518
Companies
4
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.2M | 4,422 | 3,511 |
| 2023 | $5.1M | 3,704 | 2,883 |
| 2022 | $1.3M | 2,327 | 1,698 |
| 2021 | $3.4M | 1,676 | 1,298 |
| 2020 | $3.2M | 1,502 | 1,030 |
| 2019 | $4.2M | 2,440 | 1,332 |
| 2018 | $4.6M | 3,026 | 1,447 |
| 2017 | $16.52 | 1 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $10.6M | 11 | 46.2% |
| Unspecified | $4.2M | 274 | 18.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3.6M | 698 | 15.7% |
| Consulting Fee | $2.4M | 1,278 | 10.3% |
| Travel and Lodging | $1.1M | 2,320 | 4.9% |
| Food and Beverage | $616,035 | 14,293 | 2.7% |
| Grant | $306,524 | 31 | 1.3% |
| Education | $67,928 | 172 | 0.3% |
| Space rental or facility fees (teaching hospital only) | $60,038 | 2 | 0.3% |
| Honoraria | $20,900 | 3 | 0.1% |
| Entertainment | $702.79 | 14 | 0.0% |
| Gift | $582.12 | 2 | 0.0% |
Payments by Type
General
$18.7M
18,824 transactions
Research
$4.2M
274 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty | KCI USA, Inc | $869,887 | 0 |
| A Prospective, Single-arm, Multi-center, Open Label Trial Evaluating the Continuous Application of Prevena Therapy for up to 14 days | KCI USA, Inc. | $299,009 | 0 |
| KCI.PREVENA.2017.01 Post-market, Randomized, Open-Label, Multicenter, Study to Evaluate the Effectiveness of Closed Incision Negative Pressure Therapy versus Standard of Care Dressings in Reducing Surgical Site Complications in Subjects with Revision of a Failed Total Knee Arthroplasty PROMISES | KCI USA, Inc | $248,390 | 0 |
| A Prospective, Single-arm, Multi-center, Open Label Trial Evaluating the Continuous Application of Prevena Therapy for up to 14 days | Solventum Corporation | $199,760 | 0 |
| UTAH Breast recon registry - Agarwal - Griffin | KCI USA, Inc. | $193,066 | 0 |
| Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty PROMISES | KCI USA, Inc | $156,248 | 0 |
| KelaHealth - Vascular Surgery Collaborative Research Agreement June 2021 | KCI USA, Inc. | $124,650 | 0 |
| Wound Registry for Patients Undergoing Surgical Wound Debridements of the Upper or Lower Extremities | KCI USA, Inc. | $104,105 | 0 |
| Prevena Study at Northwestern University / Dr. Robert Galiano Year 1 | KCI USA, Inc. | $102,167 | 0 |
| Multicenter randomized controlled trial of a negative pressure incision management system in high risk vascular surgery patients | KCI USA, Inc | $101,329 | 0 |
| University of Utah - Dr Agarwal - Collaborative Clinical Research related to the Breast Reconstruction Registry | KCI USA, Inc. | $96,533 | 0 |
| Negative Pressure Wound Therapy for prevention of surgical site infections in high risk patients with diabetes and morbid obesity | KCI USA, Inc. | $84,000 | 0 |
| Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty | KCI USA, Inc. | $83,587 | 0 |
| Evaluation of Negative Pressure Wound Therapy for Reduction of Postoperative Surgical Site Infection in Patients Undergoing Colorectal and Hepatopancreatobiliary Surgery | KCI USA, Inc. | $70,006 | 0 |
| NPWT and INPWT-Mediated Modulation of Lymphatic Vessels in Diabetic Wound Healing: A Possible Novel Mechanism of Action and Novel Indications for NPWT. | KCI USA, Inc. | $65,000 | 0 |
| A Randomized Controlled Trial Evaluating the Outcomes for Incisional Application of Negative Pressure for Nontraumatic Lower Extremity Amputations A Pilot Study | KCI USA, Inc | $57,443 | 0 |
| Prophylactic Negative Pressure Wound Therapy in Obese Women at Cesarean a multicenter Randomized Trial | KCI USA, Inc | $57,100 | 0 |
| Use of Negative Pressure Wound Therapy in Morbidly Obese Women after Cesarean Delivery a Randomized Controlled Trial | KCI USA, Inc | $56,367 | 0 |
| Wound Registry for Patients Undergoing Surgical Wound Debridements of the Upper or Lower Extremities | KCI USA, Inc | $55,591 | 0 |
| Application of Prevena Incision Management System in Complex Abdominal Wall Reconstruction with Biological mesh and major laprotomies. | KCI USA, Inc. | $50,000 | 0 |
Top Doctors Receiving Payments for PREVENA — Page 458
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Obstetrics & Gynecology | Lincoln, NE | $11.29 | 1 |
| , M.D | Reproductive Endocrinology | Lincoln, NE | $11.29 | 1 |
| , MD | Student in an Organized Health Care Education/Training Program | Cincinnati, OH | $11.28 | 1 |
| Fernando Ravessoud | — | Las Cruces, NM | $11.28 | 1 |
| , M.D | Trauma Surgery | Saint Louis, MO | $11.27 | 1 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Lakeland, FL | $11.27 | 1 |
| , M.D | Surgery | Saint Louis, MO | $11.27 | 1 |
| , MD | Emergency Medicine | Saint Louis, MO | $11.27 | 1 |
| , M.D | Surgical Critical Care | Saint Louis, MO | $11.27 | 1 |
| , D.P.M | Foot & Ankle Surgery | Bartlesville, OK | $11.26 | 1 |
| , DPM | Foot & Ankle Surgery | Vinita, OK | $11.26 | 1 |
| , D.P.M | Foot & Ankle Surgery | Temple Terrace, FL | $11.25 | 1 |
| , M.D | Orthopaedic Surgery | Sarasota, FL | $11.24 | 1 |
| , MD | Maternal & Fetal Medicine | Everett, WA | $11.24 | 1 |
| , DPM, FACAFAS | Military Health Care Provider | Bradenton, FL | $11.23 | 1 |
| , M.D | Plastic Surgery | Marrero, LA | $11.21 | 1 |
| , MD | Colon & Rectal Surgery | Sebring, FL | $11.21 | 1 |
| , M.D | Obstetrics & Gynecology | Tyler, TX | $11.20 | 1 |
| , M.D | Obstetrics & Gynecology | Augusta, GA | $11.19 | 1 |
| , M.D | Obstetrics & Gynecology | Augusta, GA | $11.19 | 1 |
| , DO | Obstetrics & Gynecology | El Centro, CA | $11.19 | 1 |
| , MD | Obstetrics & Gynecology | Augusta, GA | $11.19 | 1 |
| , M.D | Obstetrics & Gynecology | Augusta, GA | $11.19 | 1 |
| , MD | Obstetrics & Gynecology | Augusta, GA | $11.19 | 1 |
| , MD | Obstetrics & Gynecology | Augusta, GA | $11.19 | 1 |
Ad
Manufacturing Companies
- KCI USA, Inc. $12.9M
- KCI USA, Inc $8.8M
- Solventum Corporation $1.2M
- 3M Company $36,000
Product Information
- Type Device
- Total Payments $22.9M
- Total Doctors 11,518
- Transactions 19,098
About PREVENA
PREVENA is a device associated with $22.9M in payments to 11,518 healthcare providers, recorded across 19,098 transactions in the CMS Open Payments database. The primary manufacturer is KCI USA, Inc.
Payment data is available from 2017 to 2024. In 2024, $1.2M was paid across 4,422 transactions to 3,511 doctors.
The most common payment nature for PREVENA is "Royalty or License" ($10.6M, 46.2% of total).
PREVENA is associated with 20 research studies, including "Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty" ($869,887).